Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group (Q43582734)
Jump to navigation
Jump to search
scientific article published in May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group |
scientific article published in May 2001 |
Statements
1 reference
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group (English)
1 reference
1 reference
1 reference
Clemons MJ
1 reference
Judson I
1 reference
Harris M
1 reference
van Hoesel Q
1 reference
le Cesne A
1 reference
van Oosterom AT
1 reference
Kamby C
1 reference
Hermans C
1 reference
Whittaker J
1 reference
Donato di Paola E
1 reference
Verweij J
1 reference
Nielsen S
1 reference
1 May 2001
1 reference
1 reference
37
1 reference
7
1 reference
870-877
1 reference
Identifiers
1 reference
1 reference